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Protozoan apicomplexan parasites from the
genus Cryptosporidium infect a wide variety of
hosts (1). The parasites are transmitted to
humans through contaminated drinking water
(2), contact with infected animals, and contact
with infected persons (3). In the immunocompe-
tent, cryptosporidiosis manifests itself as self-
limited diarrhea, sometimes accompanied by
nausea, abdominal cramps, fever, and vomiting.
In the immunodeficient, however, cryptosporidiosis
may be severe, chronic, and life-threatening (4).
Cross-infection experiments, in which
Cryptosporidium oocysts were obtained from
animals of one species and fed to animals of
another species, have investigated the host
specificity of this parasite (5). The differences
observed in the host range of putative C. parvum
isolates led to a proposal to establish the
Cryptosporidium isolate originating from guinea
pigs, morphologically indistinguishable from
C. parvum, as a new speciesC. wrairisolely
on the basis of experimental infection (6). The
possibility of many Cryptosporidium species
fostered the development of techniques suitable
for typing isolates. Commonly used techniques
are isoenzyme analysis (7), Western blotting
(8,9), random amplified polymorphic DNA
analysis (10-12), polymerase chain reaction
restriction fragment length polymorphism (PCR-
RFLP) analysis (13,14), and PCR followed by
DNA sequencing (11,15-19).
Early studies of the polymorphism of isolates
classified as C. parvum found significant
geographic variation among isolates (20) in the
region coding for the small subunit ribosomal
RNA (SSU-rRNA), commonly used for taxonomic
classification. Recently, it has been shown (21)
that one of the sequences used in this analysis
(22) was erroneously identified as a C. parvum
sequence, while in fact it was C. muris. More
recent work (e.g., Le Blancq et al. [23] and
GenBank entry AF040725) has shown that the
SSU-rRNA region of the C. parvum zoonotic
(bovine) genotype does not show heterogeneity
and is practically identical to the sequence
submitted to GenBank in 1993 (accession
number L16996, [24,25]).
Recently, consistent results of typing bovine
and human C. parvum isolates led to
unequivocal recognition of two genotypes of
C. parvum. These two genotypes were reproduc-
ibly differentiated by sequencing the SSU-rRNA
coding region (16), sequencing the Cryptosporidium
thrombospondin-related adhesion protein (TRAP-
C2) gene (17), and PCR-RFLP analysis of the
Cryptosporidium oocyst wall protein (COWP)
gene (15). Thus far, the anthroponotic genotype
(genotype 1) has been found only in infected
humans, while the zoonotic genotype (genotype
2) has been found both in infected humans and in
livestock, e.g., cows, lambs, goats, and horses.
The published partial SSU-rRNA sequence of
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the C. parvum genotype 1 (16) is identical to the
Cryptosporidium SSU-rRNA sequence that we
observed in PCR-amplified DNA from a patient
with AIDS (GenBank accession number L16997).
That the data from different laboratories for
these two genotypes were reproducible calls into
question the recent conclusion of Tzipori and
Griffiths (26) that there are no clearly defined
and fully characterized reference strains of
Cryptosporidium.
Other new Cryptosporidium genotypes have
been identified in various animals (pigs, mice,
cats, and koalas) by sequencing the region coding
for SSU-rRNA (16,27,28). The cat genotype is
thought to represent C. felis (28). When
morphologic and other data are available for
these new genotypes, they may be recognized as
new Cryptosporidium species.
We present results of typing Cryptosporidium
isolates by direct sequencing the variable region
of the SSU-rRNA amplified from fecal specimens
with Cryptosporidium genus-specific diagnostic
PCR primers (25). Applying this method to a set
of specimens from a 3-year longitudinal study on
the risk for enteric parasitosis and chronic
diarrhea in immunodeficient patients with a low
CD4+ count, we found the first human cases of
infection by C. felis and by a newly identified
zoonotic Cryptosporidium species possibly origi-
nating from a dog.
The Study
All analyzed specimens were collected from
January 1991 through September 1994 in a
study assessing the impact of enteric parasite-
associated diarrhea in persons infected with HIV
(29). Study participants answered comprehen-
sive questionnaires concerning clinical and
epidemiologic information and provided stool
specimens monthly. All stool specimens were
examined for C. parvum by Kinyoun carbol-
fuchsin modified acid-fast stain (30) and direct
immunofluorescence (31). Stained slides were
examined by observing 200 oil-immersion fields.
C. parvum was associated with 18 (5.1%) of the
354 acute episodes and 36 (12.9%) of the chronic
episodes of diarrhea reported by the partici-
pants. All specimens from this study were
preserved in separate vials of 10% formalin and
polyvinyl alcohol (Para-Pak Stool System;
Meridian Diagnostics, Inc., Cincinnati, OH) and
thus were not suitable for molecular analysis.
Some specimens were originally aliquoted and
stored without preservation at -80°C. Of this set,
we selected 18 available specimens for 10
randomly chosen Cryptosporidium-positive pa-
tients for this study.
An aliquot of approximately 300 µl of each
stool specimen was suspended in 1 ml of 0.01 M
phosphate-buffered saline, pH 7.2, containing
0.01 M of EDTA (PBS-EDTA), and the
suspension was centrifuged at 14,000 x g, 4°C for
5 minutes. The pellet from this centrifugation
was washed two more times under the same
conditions. The pellet was resuspended in 300 µl
of PBS-EDTA and used for DNA extraction,
performed with the FastPrep disrupter and the
FastDNA kit (BIO 101, Inc., Vista, CA) (32).
Extracted DNA was stored at 4°C until PCR
amplification.
Cryptosporidium genus-specific primers
(CPBDIAGF and CPBDIAGR) were used to
amplify the Cryptosporidium SSU-rRNA vari-
able region (24,25). The conditions for PCR were
95°C for 15 minutes; 45 cycles of denaturation at
94°C for 30 seconds, annealing at 65°C for 30
seconds, extension at 72°C for 1 minute, 30
seconds; followed by extension at 72°C for 9
minutes; and finished with a hold step at 4°C.
PCR products were analyzed by electro-
phoresis on 2% SeaKem GTG agarose (Cat. No.
50074, FMC Bioproducts, Rockland, ME),
stained with ethidium bromide, and visualized
on UV transilluminator. The size of the
diagnostic fragment amplified with these
primers for C. parvum genotype 1 (GenBank
accession number L16997) was 438 bp, for
C. parvum genotype 2 (L16996) 435 bp, for
C. baileyi (L19068) 428 bp, and for C. muris
(L19069) 431 bp.
PCR products were purified by using the
Wizard PCR Preps kit (Cat. No. A7170, Promega,
Madison, WI). Sequencing reactions were done
with the Perkin Elmer Big Dye kit (Cat. No.
4303149, PE Biosystems, Foster City, CA) and
analyzed on the Perkin Elmer ABI 377 automatic
DNA sequencer. Sequences were assembled by
using the program SeqMan II (DNASTAR Inc.,
Madison, WI). Sequences were aligned with the
program MACAW (33) and analyzed by
programs from the PHYLIP (phylogeny infer-
ence program) package (34).
Findings
After the 18 fecal specimens were retrieved
from storage and processed for PCR with the446 Emerging Infectious Diseases Vol. 5, No. 3, MayJune 1999
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Figure 1. Agarose gel (2%) visualization of diagnostic
polymerase chain reaction products of four
Cryptosporidium genotypes. Lane S, standard 100-bp
ladder; lane 1, patient 53, zoonotic genotype 2; lane 2,
patient 119, Cryptosporidium sp. (zoonotic, canine
genotype); lane 3, patient 84, C. felis (zoonotic, feline
genotype); lane 4, patient 75, anthroponotic genotype 1.
Table 1. Cryptosporidium genotypes for 10 selected
patients in this study
Patient no. Band sizea (bp)  C. parvum genotype
53 435 Zoonotic (genotype 2)
75, 124, 153 438 Anthroponotic
  278, 554   (genotype 1)
119 429 Cryptosporidium sp.
  (canine genotype)
84, 184, 485 455 C. felis
aSize of the Cryptosporidium diagnostic  band obtained with
the CPBDIAGF/CPBDIAGR PCR primer pair
CPBDIAGF/CPBDIAGR diagnostic primer set,
visualization of PCR products on 2% agarose gels
found two different sizes of diagnostic bands. The
size of the Cryptosporidium diagnostic bands for
patients 53, 75, 119, 124, 153, 278, and 554 did
not differ significantly from the size of the
standard band (approximately 435 bp) obtained
with cloned SSU-rRNA for the C. parvum
genotype 2 (Figure 1, lane 1). On the other hand,
the  Cryptosporidium diagnostic bands in
samples from patients 84, 184, and 485 were
visibly larger, approximately 450 bp (Figure 1,
lane 3 shows data for patient 84).
DNA sequence analysis showed four types of
sequences (Table 1). The sequence of the
diagnostic band from patient 53 was 435 bp long
and was identical to the corresponding fragment
of the C. parvum genotype 2 (GenBank accession
number L16996) SSU-rRNA. The diagnostic
bands in patients 75, 124, 153, 278, and 554 were
438 bp long and were identical to the
corresponding fragment of the C. parvum
genotype 1 SSU-rRNA (GenBank accession
number L16997). The sequence from patient 119
was 429 bp long; the diagnostic bands from
patients 84, 184, and 485 were 455 bp long and
were identical to each other. Sequence similarity
searches of GenBank database and molecular
phylogeny analysis of the two latter types of
sequences showed that, while they were not
identical to any sequences in GenBank, they
clustered within other representative SSU-rRNA
sequences from the genus Cryptosporidium
(results not shown). In addition, these sequences
were significantly different from recently
reported partial SSU-rRNA sequences
(16,19,27,28). The 429-bp-long diagnostic frag-
ment in patient 119 was identical to a recently
identified canine C. parvum isolate SSU-rRNA
sequence (GenBank accession number
AF112576). The longest sequence (455 bp) from
patients 84, 184, and 495 was identical in a
100-bp overlap to an updated sequence
(GenBank accession number AF097430) for
C. felis (also called feline C. parvum genotype)
(28). Alignment of these sequences is shown in
Figure 2. In the hypervariable alignment region
(from position 101 to 110), all genotypes display a
variable number of thymidines. Genotype 1 has
the longest stretch, 11 thymidines, while the
Cryptosporidium sp. (canine genotype) has only
one. The sequence for C. felis has five insertions
at alignment positions 45, 86, 111, 187, and 218,
as well as one deletion of two thymidines at
positions 197 and 198. Apart from the difference
in the hypervariable region, the Cryptosporidium
sp. (canine genotype) has a deletion of two bases
at positions 49 and 50.447 Vol. 5, No. 3, MayJune 1999 Emerging Infectious Diseases
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Figure 2. Alignment of the Cryptosporidium small subunit ribosomal DNA (SSU-rRNA) diagnostic fragments
obtained with the CPBDIAGF/CPBDIAGR polymerase chain reaction primer pair for the four genotypes. Only
the first 300 columns of the alignment are shown, as the remaining columns were identical for all genotypes.
Gaps are shown with dashes (-), and bases identical to the base in the first row (C. felis) are shown with dots
(.). Numbers to the right of the alignment show sequence positions for each genotype. The sequences for the
SSU-rRNA diagnostic fragment of all four genotypes were submitted to GenBank and were assigned accession
numbers AF087574, AF087575, AF087576, and AF087577.
Table 2. Persistence of Cryptosporidium genotypes in patientsa
  No. of
Patient  available Month of follow-up
no. specimens 1 2 34567891 0 1 1 1 2
  53 1 B
  75 2 H - - H
  84 4 F - F - F F






5 5 4 4 H - -----H -H - H
a B, C. parvum genotype 2 (zoonotic, bovine); C, Cryptosporidium sp. (zoonotic, canine); F, C. felis (zoonotic, feline); H, C. parvum
genotype 1 (anthroponotic); -, specimen not available.
Results of genotyping the 18 specimens are
in Table 2. For patients 53, 124, 153, 184, 278,
and 485, only a single specimen was available.
For other patients (e.g., patient 554), four
specimens collected during 12 months were
available. The same Cryptosporidium genotype
persisted throughout a patients infection.
Conclusions
Using the sequence of a diagnostic fragment
of SSU-rRNA, as well as two well-established
genotypes of C. parvum (anthroponotic genotype
1 and zoonotic genotype 2), we detected two new
Cryptosporidium genotypes. The first, in
patients 84, 184, and 485, was identical to the448 Emerging Infectious Diseases Vol. 5, No. 3, MayJune 1999
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feline  Cryptosporidium genotype (28), also
described as C. felis. The second, in two
specimens from patient 119, represents the
newly identified Cryptosporidium sp. found in a
sequence originating from a dog (GenBank
accession number AF112576).
New taxons may be established within the
genus  Cryptosporidium on the basis of the
isolates host range together with molecular
data, even though morphologic criteria are
apparently lacking. We propose to use C. felis
Iseki, 1979, instead of feline C. parvum
genotype; we believe that the anthroponotic
genotype 1 of C. parvum and the Cryptosporidium
sp. (canine genotype) described here should be
named as distinct species. Although the
taxonomy of protists is morphology-based, the
taxonomy of bacteria is being reevaluated on the
basis of molecular data (35). There is no reason to
use different approaches to these two kingdoms,
nor is it necessary to postulate that the basis for
speciation of Cryptosporidium remains ambigu-
ous or that molecular data lend little support to
separation of Cryptosporidium into distinct,
valid species (26). Further, we see no evidence for
the unconventional conclusions of Tzipori and
Griffiths that ...genetic markers in C. parvum
can change upon passage to a different host,
possibly through a selective mechanism favoring
different populations (26) nor for those of
Widmer (21) that ...genetic studies and
experimental infections suggest that a selective
mechanism triggered by a change in the
intestinal environment might be involved in
shaping the genetic make-up of C. parvum
populations.
The finding of new Cryptosporidium geno-
types in immunodeficient patients might suggest
a unique susceptibility to infections by divergent
Cryptosporidium species circulating in compan-
ion animals or livestock. However, recent
identification of C. felis in a cow (36) may indicate
a complex pattern of flow of different
Cryptosporidium species in the environment.
When more data on the distribution of these
species become available, public health and
preventive measures will need to be reevaluated,
and isolates may need to be renamed to reflect
their natural history. Finally, it is clear that
Kinyoun carbol-fuchsin modified acid-fast stain
(30) and direct immunofluorescence (31) could
detect all genotypes, but this may not be true for
diagnostic reagents that may be affected directly
(PCR) or indirectly (Ab) by the genetic
composition of the new Cryptosporidium isolates
reported here. Thus, discovery of these new
Cryptosporidium genotypes in human
cryptosporidiosis should cause existing diagnos-
tic tools to be reevaluated.
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